Se connecter pour consulter les tarifs organisationnels et contractuels.
Sélectionner une taille de conditionnement
Changer de vue
A propos de cet article
Formule linéaire :
CH3SCH2CH2CH(NH2)COOH
Numéro CAS:
Poids moléculaire :
149.21
UNSPSC Code:
12352209
NACRES:
NA.75
PubChem Substance ID:
EC Number:
200-432-1
Beilstein/REAXYS Number:
636185
MDL number:
Service technique
Besoin d'aide ? Notre équipe de scientifiques expérimentés est là pour vous.
Laissez-nous vous aiderproduct line
BioReagent
Quality Level
assay
≥99%
form
powder
technique(s)
cell culture | insect: suitable, cell culture | mammalian: suitable
color
white
mp
280 °C (dec.) (lit.)
solubility
H2O: 50 mg/mL, clear, colorless
SMILES string
CSCCC(N)C(O)=O
InChI
1S/C5H11NO2S/c1-9-3-2-4(6)5(7)8/h4H,2-3,6H2,1H3,(H,7,8)
InChI key
FFEARJCKVFRZRR-UHFFFAOYSA-N
Application
Use in mammalian and insect cell culture applications where mixed isomers are indicated.
Classe de stockage
11 - Combustible Solids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
Faites votre choix parmi les versions les plus récentes :
Déjà en possession de ce produit ?
Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.
Pilar Lloris-Garcerá et al.
Journal of molecular biology, 426(11), 2246-2254 (2014-04-03)
The increasing number of solved membrane protein structures has led to the recognition of a common feature in a large fraction of the small-molecule transporters: inverted repeat structures, formed by two fused homologous membrane domains with opposite orientation in the
Shawn Flanagan et al.
Antimicrobial agents and chemotherapy, 59(1), 178-185 (2014-10-22)
Prolonged treatment with the oxazolidinone linezolid is associated with myelosuppression, lactic acidosis, and neuropathies, toxicities likely caused by impairment of mitochondrial protein synthesis (MPS). To evaluate the potential of the novel oxazolidinone tedizolid to cause similar side effects, nonclinical and
Camilla Schalin-Jäntti et al.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 54(5), 739-747 (2013-04-05)
All patients with primary hyperparathyroidism should undergo localization studies before reoperation, but it is not known which method is most accurate. The purpose of this prospective study was to compare the performance of planar scintigraphy with (123)I/(99m)Tc-sestamibi, (99m)Tc-sestamibi SPECT (SPECT/CT)